For a chance to win a $500 Amazon Gift Card (or equivalent currency) cast your vote for the new products which have made the most difference to clinical diagnostics
Leading HPLC analyzer manufacturer Tosoh Europe partners with EKF for Quo-Test HbA1c point-of-care analyzer
Dr Kirk McManus describes how 3D cell culture is advancing his cancer research
For transient gene repression with CRISPR-level specificity
Horizon's CRISPRi guide RNA in an easy to deliver lentiviral format
Fujirebio adds another two markers to its fully automated blood-based biomarker portfolio
New assays are pre-designed for fast and reliable research in the identification of genetic mutations
This proprietary technology allows for rapid, reproducible differentiation of human iPSC-derived excitatory, GABAergic, dopaminergic and cholinergic neurons
The new product line includes the MutaPLEX RT-PCR assay and ELISA kits to detect IgM and IgG antibodies
Use our proprietary algorithms to design custom Cas9 guide RNAs
34-gene panel for assessing risk of 15 inherited cancers among new Quest Vantage™ test services to be highlighted during the 2016 ASCO Annual Meeting
Abcam scientist Dr. Yongwon Kwon discusses a new method that could help scientists simplify their gene-editing processes and extend the validation of cancer cells
Authors successfully demonstrate transport of new-gene editing technology to ‘cut out’ HIV DNA from infected cells
This special feature explores the impact of the human microbiome on disease development and highlights the latest innovations driving microbiome research
Key opinion leaders’ expertise to guide design of new gene panels for GeneReader NGS
Pooled CRISPR screening with 10x genomics compatibility for discovery at single cell resolution
